As observed in our in vitro models, RNA sequencing analysis showed decreased BUB1B expression in the prostate cancer tissue relative to the normal counterpart in both BUB1B carriers, while tumor/normal matched prostate tissues from non-carriers showed an inverse pattern (Fig. 3B). Here, BUB1B is linked to prostate carcinoma.